Skip to Content
Merck
  • An intravenous implantable glucose/dioxygen biofuel cell with modified flexible carbon fiber electrodes.

An intravenous implantable glucose/dioxygen biofuel cell with modified flexible carbon fiber electrodes.

Lab on a chip (2012-12-18)
Fernanda C P F Sales, Rodrigo M Iost, Marccus V A Martins, Maria C Almeida, Frank N Crespilho
ABSTRACT

An intravenous implantable glucose/dioxygen hybrid enzyme-Pt micro-biofuel cell (BFC) was investigated. In this miniaturized BFC, a flexible carbon fiber (FCF) microelectrode modified with neutral red redox mediator and glucose oxidase was used as the bioanode, and an FCF modified with platinum nanoparticles stabilized on PAMAM-G4 dendrimer was used as the cathode. In vitro experiments conducted using the BFC in a phosphate buffer solution (50 mmol L(-1), pH = 7.2) and glucose (47 mmol L(-1)) showed high electrocatalytic performance with an open circuit voltage (OCV) of 400 mV, a maximum current density of 2700 μA cm(-2) at 0.0 V and a maximum output power of 200 μW cm(-2) at 250 mV. Under physiological conditions, glucose from rat blood is used as a fuel in anodic reactions and dissolved molecular oxygen is used as the oxidizing agent on the cathode. For in vivo experiments, the BFC was inserted into the jugular vein of a living rat (Rattus novergicus) using a catheter (internal diameter 0.5 mm). The power density of the implantable BFC was evaluated over a period of 24 h, and an OCV of 125 mV with a maximum power density of 95 μW cm(-2) was obtained at 80 mV.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glucose Oxidase from Aspergillus niger, Type VII, lyophilized powder, ≥100,000 units/g solid (without added oxygen)
Sigma-Aldrich
Glucose Oxidase from Aspergillus niger, Type X-S, lyophilized powder, 100,000-250,000 units/g solid (without added oxygen)